Cargando…
Short-term safety and efficacy of Preserflo™ Microshunt in glaucoma patients: a multicentre retrospective cohort study
BACKGROUND/AIMS: To evaluate 1-year success rates and safety profile of Preserflo™ Microshunt in glaucoma patients. METHODS: Retrospective multicentre cohort study of 100 consecutive eyes (91 patients) from four tertiary-referral glaucoma centres. Four intraocular pressure (IOP) criteria were define...
Autores principales: | Bhayani, Raj, Martínez de la Casa, Jose Maria, Figus, Michele, Klabe, Karsten, Rabiolo, Alessandro, Mercieca, Karl |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8916945/ https://www.ncbi.nlm.nih.gov/pubmed/35277663 http://dx.doi.org/10.1038/s41433-022-01995-7 |
Ejemplares similares
-
Preliminary results of Preserflo Microshunt versus Preserflo Microshunt and Ologen implantation
por: Vastardis, Iraklis, et al.
Publicado: (2021) -
Efficacy and Safety of the Preserflo Microshunt With Mitomycin C for the Treatment of Open Angle Glaucoma
por: Ibarz Barberá, Marta, et al.
Publicado: (2022) -
Safety and Efficacy of the Preserflo(®) Microshunt in Refractory Glaucoma: A One-Year Study
por: Majoulet, Alexandre, et al.
Publicado: (2022) -
One-year surgical outcomes of the PreserFlo MicroShunt in glaucoma: a multicentre analysis
por: Tanner, Alexander, et al.
Publicado: (2023) -
Clinical outcomes of combined Preserflo Microshunt implantation and cataract surgery in open-angle glaucoma patients
por: Martínez-de-la-Casa, José M., et al.
Publicado: (2021)